Waters Q1 revenue $1.267B beats guidance; raises FY2026 adjusted EPS outlook to $14.40-$14.60

WATERS CORP /DE/

2026-Q1 EPS reported -$0.87 revenue$1,267,000,000

Total reported revenue of $1.267B exceeded guidance by $56M; GAAP EPS ($0.87) due to acquisition charges, Adjusted EPS $2.70 (+20% YoY).
Organic revenue grew 13% (11% constant currency), exceeding high end of guidance; driven by instrument and chemistry growth.
Acquired Biosciences & Diagnostic Solutions contributed $520M revenue from Feb 9 close, $40M above guidance.
Raising FY2026 organic constant currency growth guidance to 6.5%-8.0%, adjusted EPS to $14.40-$14.60.
Q2 2026 guidance: revenue $1.616B-$1.631B, adjusted EPS $2.95-$3.05.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

WATERS CORP /DE/ reported first quarter of 2026 results: revenue $1.267 billion, EPS Adjusted EPS of $2.70. Guidance raised.

Period: first quarter of 2026
Revenue: $1.267 billion
EPS: Adjusted EPS of $2.70
Guidance: raised
Result: reported results

Exact text from the filing

of Investor Relations – (508) 482-3448 Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results First Quarter 2026 Highlights • Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses. • Organic revenue grew 13% as

View on SEC.gov

Browse all earnings releases →

WATERS CORP /DE/ filing history →

Source: SEC EDGAR

accession 0001193125-26-204955

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.